H Sansarricq. Show Affiliations »
Abstract
Mesh: See more » Bacterial VaccinesClofazimine/therapeutic useDapsone/therapeutic useDrug Resistance, MicrobialHumansLeprosy/drug therapyLeprosy/epidemiologyLeprosy/prevention & controlMycobacterium leprae/drug effectsMycobacterium leprae/immunologyRifampin/therapeutic useWorld Health Organization
Substances: See more » Bacterial VaccinesDapsoneClofazimineRifampin
Year: 1983 PMID: 6350774 DOI: 10.5935/0305-7518.19830044
Source DB: PubMed Journal: Lepr Rev ISSN: 0305-7518 Impact factor: 0.537